D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
MetLife
MET
$62.4B
| $4M | ﹤0.01% |
48,848
-214,592
| -81% | -$17.9M |
|
2027
Adecoagro
AGRO
$1.4B
| $4M | ﹤0.01% |
423,969
-132,668
| -24% | -$1.45M |
|
2028
Webster Financial
WBS
$12.3B
| $4M | ﹤0.01% |
72,347
-301,947
| -81% | -$16.6M |
|
2029
Weyerhaeuser
WY
$17.6B
| $3.99M | ﹤0.01% |
141,681
+71,447
| +102% | +$2.23M |
|
2030
PUT
Bloom Energy
BE
$46.6B
| $3.99M | ﹤0.01% |
179,500
+112,500
| +168% | +$1.97M |
|
2031
Everspin Technologies
MRAM
$303M
| $3.98M | ﹤0.01% |
623,205
-89,552
| -13% | -$555K |
|
2032
Valley National Bancorp
VLY
$7.9B
| $3.97M | ﹤0.01% |
438,164
-291,027
| -40% | -$2.82M |
|
2033
CALL
Cytokinetics
CYTK
$10.6B
| $3.97M | ﹤0.01% |
84,300
-35,000
| -29% | -$1.82M |
|
2034
PUT
Vale
VALE
$62.3B
| $3.96M | ﹤0.01% |
447,000
-674,800
| -60% | -$6.87M |
|
|
OPI
2035
DELISTED
Office Properties Income Trust
OPI
| $3.96M | ﹤0.01% |
3,965,620
+2,636,589
| +198% | +$4.07M |
|
2036
PUT
Noble Corp
NE
$6.54B
| $3.96M | ﹤0.01% |
126,200
+71,800
| +132% | +$2.38M |
|
2037
Driven Brands
DRVN
$2.47B
| $3.96M | ﹤0.01% |
245,271
-258,068
| -51% | -$4.05M |
|
2038
Caleres
CAL
$432M
| $3.95M | ﹤0.01% |
170,735
+29,880
| +21% | +$875K |
|
2039
PUT
BioMarin Pharmaceuticals
BMRN
$11.9B
| $3.94M | ﹤0.01% |
60,000
+26,200
| +78% | +$1.75M |
|
2040
CALL
Tyson Foods
TSN
$21.5B
| $3.94M | ﹤0.01% |
68,600
+15,000
| +28% | +$906K |
|
2041
Imperial Oil
IMO
$62.3B
| $3.93M | ﹤0.01% |
63,878
+8,588
| +16% | +$623K |
|
2042
Digimarc Corp
DMRC
$143M
| $3.93M | ﹤0.01% |
105,028
+50,690
| +93% | +$1.66M |
|
|
SF
2043
Stifel
SF
$12.4B
| $3.93M | ﹤0.01% |
55,602
-53,933
| -49% | -$3.85M |
|
2044
First Internet Bancorp
INBK
$233M
| $3.93M | ﹤0.01% |
109,121
-8,011
| -7% | -$304K |
|
2045
CALL
Pinterest
PINS
$13.7B
| $3.93M | ﹤0.01% |
135,400
-36,800
| -21% | -$1.16M |
|
2046
PUT
Scorpio Tankers
STNG
$3.91B
| $3.92M | ﹤0.01% |
78,900
+25,100
| +47% | +$1.43M |
|
2047
Neurocrine Biosciences
NBIX
$18.2B
| $3.92M | ﹤0.01% |
28,710
-140,744
| -83% | -$17.4M |
|
2048
CALL
American Superconductor
AMSC
$1.29B
| $3.92M | ﹤0.01% |
159,100
+54,900
| +53% | +$1.51M |
|
2049
PUT
HF Sinclair
DINO
$16.2B
| $3.91M | ﹤0.01% |
111,600
+88,600
| +385% | +$3.62M |
|
|
SAGE
2050
DELISTED
Sage Therapeutics
SAGE
| $3.91M | ﹤0.01% |
720,105
+73,073
| +11% | +$447K |
|
Similar funds
D.E. Shaw & Co's Q4 2024 Portfolio in Review
As of Q4 2024, D.E. Shaw & Co held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- D.E. Shaw & Co's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- D.E. Shaw & Co's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- D.E. Shaw & Co fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- D.E. Shaw & Co opened 591 new positions and closed 731 in Q4 2024.
- D.E. Shaw & Co's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.